Attitudes of patients with cutaneous melanoma toward prognostic testing using the 31‐gene expression profile test

OBJECTIVE: Although most patients diagnosed with early‐stage cutaneous melanoma (CM) have excellent outcomes, because of the large number diagnosed each year, many will experience recurrence or death. Prognostic testing for CM using the 31‐gene expression profile (31‐GEP) test can benefit patients b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Kelli, Siegel, Jennifer J., Morgan‐Linnell, Sonia K., LiPira, Kyleigh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883557/
https://www.ncbi.nlm.nih.gov/pubmed/35915969
http://dx.doi.org/10.1002/cam4.5047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883557/
https://www.ncbi.nlm.nih.gov/pubmed/35915969
http://dx.doi.org/10.1002/cam4.5047

Ejemplares similares